Experience With IVDR Implementation in Three Diagnostic Laboratories: Messages to EU Health Institutions, Diagnostic Healthcare Payers, and Authorities

• Bart R. Lubbers,
• Isabel Dombrink,
• Tomas Kalina,
• Mattias Hofmans,
• Morten S. Bruun,
• Simon J. Stanworth,
• Marie C. Béné,
• Konstanze Döhner,
• Monika Brüggemann,
• Elizabeth Macintyre,
• Jacques J.M. van Dongen

Affiliations

Bart R. Lubbers

1 EHA Taskforce on IVD, European Hematology Association, The Hague, The Netherlands

Isabel Dombrink

1 EHA Taskforce on IVD, European Hematology Association, The Hague, The Netherlands

Tomas Kalina

4 CLIP, Department of Paediatric Haematology/Oncology, 2nd Faculty of Medicine, Charles University, Prague, Czech Republic

Mattias Hofmans

5 Department of Laboratory Medicine, Ghent University Hospital, Belgium

Morten S. Bruun

6 Danish Medicines Agency, Copenhagen, Denmark

Simon J. Stanworth

1 EHA Taskforce on IVD, European Hematology Association, The Hague, The Netherlands

Marie C. Béné

1 EHA Taskforce on IVD, European Hematology Association, The Hague, The Netherlands

Konstanze Döhner

1 EHA Taskforce on IVD, European Hematology Association, The Hague, The Netherlands

Monika Brüggemann

1 EHA Taskforce on IVD, European Hematology Association, The Hague, The Netherlands

Elizabeth Macintyre

1 EHA Taskforce on IVD, European Hematology Association, The Hague, The Netherlands

Jacques J.M. van Dongen

1 EHA Taskforce on IVD, European Hematology Association, The Hague, The Netherlands